Articles

FDA Oks 2-Drug HIV Therapy for Previously Untreated Patients

April 08, 2019

To be eligible for dolutegravir and lamivudine, patients must have no history of antiretroviral therapy (ART) and no known or suspected substitutions associated with resistance to the individual components of the regimen.